The market addressing fibrotic diseases is rapidly expanding as medical science advances and populations age, leading to higher incidence of organ fibrosis in lungs, liver, heart, and kidneys. Fibrotic disorders like pulmonary fibrosis, liver cirrhosis, and cardiac fibrosis are increasingly recognized not only for their morbidity, but also for the urgent need for effective therapies....
Bangla